Literature DB >> 32548948

A critical role for CARD9 in pneumocystis pneumonia host defence.

Theodore J Kottom1, Vijayalakshmi Nandakumar1, Deanne M Hebrink1, Eva M Carmona1, Andrew H Limper1.   

Abstract

Caspase recruitment domains-containing protein 9 (CARD9) is an adaptor molecule critical for key signalling pathways initiated through C-type lectin receptors (CLRs). Previous studies demonstrated that Pneumocystis organisms are recognised through a variety of CLRs. However, the role of the downstream CARD9 adaptor signalling protein in host defence against Pneumocystis infection remains to be elucidated. Herein, we analysed the role of CARD9 in host defence against Pneumocystis both in CD4-depleted CARD9-/- and immunocompetent hosts. Card9 gene-disrupted (CARD9-/- ) mice were more susceptible to Pneumocystis, as evidenced by reduced fungal clearance in infected lungs compared to wild-type (WT) infected mice. Our data suggests that this defect was due to impaired proinflammatory responses. Furthermore, CARD9-/- macrophages were severely compromised in their ability to differentiate and express M1 and M2 macrophage polarisation markers, to enhanced mRNA expression for Dectin-1 and Mincle, and most importantly, to kill Pneumocystis in vitro. Remarkably, compared to WT mice, and despite markedly increased organism burdens, CARD9-/- animals did not exhibit worsened survival during pneumocystis pneumonia (PCP), perhaps related to decreased lung injury due to altered influx of inflammatory cells and decreased levels of proinflammatory cytokines in response to the organism. Finally, although innate phase cytokines were impaired in the CARD9-/- animals during PCP, T-helper cell cytokines were normal in immunocompetent CARD9-/- animals infected with Pneumocystis. Taken together, our data demonstrate that CARD9 has a critical function in innate immune responses against Pneumocystis.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  CARD9; Pneumocystis; host defence; inflammation; macrophage

Mesh:

Substances:

Year:  2020        PMID: 32548948      PMCID: PMC7755114          DOI: 10.1111/cmi.13235

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  59 in total

1.  Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity.

Authors:  Olaf Gross; Andreas Gewies; Katrin Finger; Martin Schäfer; Tim Sparwasser; Christian Peschel; Irmgard Förster; Jürgen Ruland
Journal:  Nature       Date:  2006-07-12       Impact factor: 49.962

2.  A homozygous CARD9 mutation in a Brazilian patient with deep dermatophytosis.

Authors:  Anete S Grumach; Flavio de Queiroz-Telles; Mélanie Migaud; Fanny Lanternier; Nelson Rosario Filho; Sandra M U Palma; Rosemeire Navickas Constantino-Silva; Jean Laurent Casanova; Anne Puel
Journal:  J Clin Immunol       Date:  2015-06-05       Impact factor: 8.317

3.  Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung.

Authors:  Alexander V Misharin; Luisa Morales-Nebreda; Gökhan M Mutlu; G R Scott Budinger; Harris Perlman
Journal:  Am J Respir Cell Mol Biol       Date:  2013-10       Impact factor: 6.914

4.  Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.

Authors:  Nikolaus Rieber; Roel P Gazendam; Alexandra F Freeman; Amy P Hsu; Amanda L Collar; Janyce A Sugui; Rebecca A Drummond; Chokechai Rongkavilit; Kevin Hoffman; Carolyn Henderson; Lily Clark; Markus Mezger; Muthulekha Swamydas; Maik Engeholm; Rebecca Schüle; Bettina Neumayer; Frank Ebel; Constantinos M Mikelis; Stefania Pittaluga; Vinod K Prasad; Anurag Singh; Joshua D Milner; Kelli W Williams; Jean K Lim; Kyung J Kwon-Chung; Steven M Holland; Dominik Hartl; Taco W Kuijpers; Michail S Lionakis
Journal:  JCI Insight       Date:  2016-10-20

Review 5.  Caspase recruitment domain-containing protein 9 signaling in innate immunity and inflammation.

Authors:  Susanne Roth; Jürgen Ruland
Journal:  Trends Immunol       Date:  2013-03-20       Impact factor: 16.687

6.  Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency.

Authors:  Agata Drewniak; Roel P Gazendam; Anton T J Tool; Michel van Houdt; Machiel H Jansen; John L van Hamme; Ester M M van Leeuwen; Dirk Roos; Emmanuel Scalais; Carine de Beaufort; Hans Janssen; Timo K van den Berg; Taco W Kuijpers
Journal:  Blood       Date:  2013-01-18       Impact factor: 22.113

7.  Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk.

Authors:  Sonja I Gringhuis; Jeroen den Dunnen; Manja Litjens; Michiel van der Vlist; Brigitte Wevers; Sven C M Bruijns; Teunis B H Geijtenbeek
Journal:  Nat Immunol       Date:  2009-01-04       Impact factor: 25.606

8.  Defect of CARD9 leads to impaired accumulation of gamma interferon-producing memory phenotype T cells in lungs and increased susceptibility to pulmonary infection with Cryptococcus neoformans.

Authors:  Hideki Yamamoto; Yuri Nakamura; Ko Sato; Yurie Takahashi; Toshiki Nomura; Tomomitsu Miyasaka; Keiko Ishii; Hiromitsu Hara; Natsuo Yamamoto; Emi Kanno; Yoichiro Iwakura; Kazuyoshi Kawakami
Journal:  Infect Immun       Date:  2014-01-27       Impact factor: 3.441

9.  CARD9 deficiency and spontaneous central nervous system candidiasis: complete clinical remission with GM-CSF therapy.

Authors:  Christina Gavino; Anthony Cotter; Daniel Lichtenstein; Duncan Lejtenyi; Claude Fortin; Catherine Legault; Najmeh Alirezaie; Jacek Majewski; Donald C Sheppard; Marcel A Behr; William D Foulkes; Donald C Vinh
Journal:  Clin Infect Dis       Date:  2014-04-04       Impact factor: 9.079

10.  Immune Modulation as Adjunctive Therapy for Pneumocystis pneumonia.

Authors:  Jing Wang; Terry W Wright; Francis Gigliotti
Journal:  Interdiscip Perspect Infect Dis       Date:  2011-08-29
View more
  4 in total

1.  Gene expression in lung epithelial cells following interaction with Pneumocystis carinii and its specific life forms yields insights into host gene responses to infection.

Authors:  Theodore J Kottom; Eva M Carmona; Andrew H Limper
Journal:  Microbiol Immunol       Date:  2022-03-31       Impact factor: 2.962

2.  Targeting CARD9 with Small-Molecule Therapeutics Inhibits Innate Immune Signaling and Inflammatory Response to Pneumocystis carinii β-Glucans.

Authors:  Theodore J Kottom; Eva M Carmona; Andrew H Limper
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

Review 3.  CARD9 Signaling, Inflammation, and Diseases.

Authors:  Xuanyou Liu; Bimei Jiang; Hong Hao; Zhenguo Liu
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

4.  Survey of the Transcription Factor Responses of Mouse Lung Alveolar Macrophages to Pneumocystis murina.

Authors:  Theodore J Kottom; Kyle Schaefbauer; Eva M Carmona; Andrew H Limper
Journal:  Pathogens       Date:  2021-05-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.